The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- LoPresti Unfazed by Slow Move from Wise Dan
- Ami's Holiday Leads Prince of Wales Lineup
- Little Alexis Set for Test After Bullet Move
- Dance With Fate Euthanized After Accident
- Keeneland Dirt Installation July 21, 2014
- Saratoga to Hold 'Low Roller' Tourney Monday
- Untapable Favored in Haskell Against Boys
- EquiLottery Touts Horsemen Group's Support
- Paul Messara New Manager at Arrowfield Stud
- Next Year's OBSC March to be Open Format